Inicio

Estudios importantes sobre hipertension arterial de Cuba y el mundo

  

The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension

Por: CHAIRPERSON: Kazuaki SHIMAMOTO (Sapporo Medical University)
WRITING COMMITTEE: Katsuyuki ANDO (University of Tokyo), Toshihiko ISHIMITSU (Dokkyo Medical University). Sadayoshi ITO (Tohoku University), Masaaki ITO (Mie University), Hiroshi ITOH (Keio University), Yutaka IMAI (Tohoku University), Tsutomu IMAIZUMI (Kurume University), Hiroshi IWAO (Osaka City University), Shinichiro UEDA (University of the Ryukyus), Makoto UCHIYAMA (Uonuma Kikan Hospital), Satoshi UMEMURA (Yokohama City University), Yusuke OHYA (University of the Ryukyus), Katsuhiko KOHARA (Ehime University), Hisashi KAI (Kurume University), Naoki KASHIHARA (Kawasaki Medical School), et al.  Hypertension Research (2014) 37, 254–255.

Introduction

The Japanese Society of Hypertension revised the Japanese Society of Hypertension Guidelines for the Management of Hypertension in 2009 (JSH 2009) and published the JSH 2014. Basically, the JSH 2014 was prepared according to strategies to prepare the JSH 2009 and the ‘Guidance for the Preparation of Treatment Guidelines in 2007’ established by the Medical Information Network Distribution Service. In the ‘Introduction’ section, methods to prepare the JSH 2014 are introduced.

Chapter 1. Epidemiology of hypertension.
Chapter 2. Measurement and clinical evaluation of blood pressure
Chapter 3. Principles of treatment
Chapter 4. Lifestyle modifications
Chapter 5. Treatment with antihypertensive drugs
Chapter 6. Hypertension associated with organ damage
Chapter 7. Hypertension complicated by other diseases
Chapter 8. Hypertension in the elderly
Chapter 9. Dementia
Chapter 10. Hypertension in women
Chapter 11. Hypertension in children
Chapter 12. Hypertension under special conditions
Chapter 13. Secondary hypertension
References
List of Abbreviations and Acronyms

Artículos Originales

Predictors of plasma and urinary catecholamine levels in normotensive and hypertensive men and women

Journal of Human HypertensionPor: A R Saxena, B Chamarthi, G H Williams, P N Hopkins y E W Seely.  Journal of Human Hypertension (2014) 28, 292–297.

Age, sex, hypertension and dietary sodium are proposed to affect plasma and urinary catecholamines. Yet no prior study has examined the simultaneous effects of these factors within the same study population. So results may have been confounded by factors not determined. We investigate, for the first time, the impact of simultaneously determined predictors of plasma and urinary catecholamines and the relationship of catecholamines with the diagnosis of hypertension. Hypertensive and normotensive subjects (n=308) were studied off antihypertensives in liberal and low sodium balance. 24?h urinary catecholamines (norepinephrine and epinephrine) were measured. Plasma catecholamines were measured supine after overnight fast.

Comentando

Demografía y características clínicas de la hipertensión resistente en 6.292 pacientes en atención primaria

ComentadoPor: Teresa Gijón-Condeab,  Auxiliadora Gracianib y José R. Banegas.  Rev Esp Cardiol. 2014;67:270-6. - Vol. 67 Núm.04 DOI:10.1016.

Se ha publicado recientemente la prevalencia de hipertensión resistente pero no existen estudios específicos sobre su demografía. Este estudio tiene como objetivo analizar la demografía y las características clínicas de la hipertensión resistente en una amplia muestra de pacientes en atención primaria.  De cada 4 pacientes con hipertensión resistente, 1 es > 80 años. La hipertensión resistente está asociada a la enfermedad cardiovascular, al varón < 50 años y la mujer > 80. La prevalencia de enfermedad cardiovascular en el anciano con hipertensión resistente es elevada.

Factores de Riesgo

Blood pressure variability and outcome after acute intracerebral haemorrhage: a post-hoc analysis of INTERACT2, a randomised controlled trial

Riesgo cardiovascularPor: Lisa Manning MBChB , Yoichiro Hirakawa MD, Hisatomi Arima PhD,  Xia Wang MMed, Prof John Chalmers MD, Prof Jiguang Wang PhD, Prof Richard Lindley MD, Emma Heeley PhD, Candice Delcourt MD, Prof Bruce Neal MD, Prof Pablo Lavados MD, Prof Stephen M Davis MD, Prof Christophe Tzourio MD j k, Prof Yining Huang MD, Prof Christian Stapf MD, Prof Mark Woodward PhD, Prof Peter M Rothwell FMedSci, Prof Thompson G Robinson MD y  Prof Craig S Anderson MD.  The Lancet Neurology, Volume 13, Issue 4, Pages 364 - 373, April 2014

Stroke is a major cause of premature death and disability. The most serious and least treatable form—acute intracerebral haemorrhage—affects more than 1 million people each year worldwide.1 High blood pressure is a risk factor for stroke, particularly for both incident and recurrent intracerebral haemorrhage, but it also predicts a poor outcome when present in the first 24 h after the onset of intracerebral haemorrhage.2—4 Thus, early intensive control of blood pressure could be a safe and effective treatment for this disorder.5, 6 INTERACT2 showed improved functional outcomes with little risk for patients with intracerebral haemorrhage who received target-driven, early, intensive treatment to reduce blood pressure

Revisiones sistemáticas

The evidence for treating hypertension in older people with dementia: a systematic review

Revisiones sistemáticasPor: L C Beishon, J K Harrison, R H Harwood, T G Robinson, J R F Gladman y S P Conroy.  Journal of Human Hypertension (2014) 28, 283–287.

Hypertension and dementia commonly co-exist in older people, yet guidance is lacking on how to manage these co-existing conditions. The aim of this systematic review was to assess the evidence for the treatment of hypertension in older people with dementia. Medline, EMBASE, Cochrane Library and the national research register archives were searched. Inclusion criteria were: randomised controlled trial of hypertension treatment, included participants aged 65+ years, participants had a diagnosis of dementia (global cognitive decline for at least 6 months affecting daily function), and the study assessed cognitive outcomes using validated tools.

Investigaciones

Patients’ preference for ambulatory versus home blood pressure monitoring

InvestigacionesPor: E G Nasothimiou, N Karpettas, M G Dafni y G S Stergiou.  Journal of Human Hypertension (2014) 28, 224–229.

Patient’s preference might influence compliance with antihypertensive treatment and thereby long-term blood pressure (BP) control. This study compared patients’ preference in using ambulatory (ABPM) versus home BP monitoring (HBPM). Subjects referred for hypertension were evaluated with 24-h ABPM and 7-day HBPM. Participants filled a questionnaire including demographics and Likert scale questions regarding their acceptance, preference, disturbance, activity restriction and feasibility of using ABPM and HBPM. A total of 119 patients were invited and 104 (87%) were included (mean age 51±11 years, 58% men, 38% time to work >8h). A total of 82% reported a positive overall opinion for HBPM versus 63% for ABPM (P<0.05). 62% considered ABPM as more reliable than HBPM but 60% would choose HBPM for their next BP evaluation (P<0.05 for both comparisons).

Artículos interesantes

En esta sección les exponemos algunos artículos publicados sobre la hipertensión arterial.    

  De la Revista: CorSalud      

Consideraciones actuales acerca de la enfermedad hipertensiva del embarzo y el puerperio

Por: MSc. Dr. Alain Cruz Portelles, MSc. Dr. Idaer M. Batista Ojeda, Dr.C. Ernesto Medrano Montero y Dr. Alfredo Ledea Aguilera.  CorSalud 2014 Ene-Mar; 6 (1).

Niveles de tratamiento y control del hipertensión arterial en el policlínico Turcios Lima

Por: Dr. Adrian A. Naranjo Domínguez, Dr. Ariel Amador González, Dr. Ángel Y. Rodríguez Navarro y Dr. Ronald Aroche Aportela.  CorSalud 2012 Oct-Dic; 4 (4).

Dispersión de la onda P en niños hipertensos. su relación con el peso corparal

Por: MSc.Dr. Elibet Chávez González, Dr.C. Emilio González Rodríguez, MSc.Dra. María del Carmen Llanes Camacho, MSc.Dra. Merlin Garí Llanes, Dra. Julieta García Sáez, Dra. Elizabet Fernández Martínez, Yosvany García Nóbrega y Raimundo Carmona Puerta. CorSalud 2012 Oct-Dic; 4 (4).

_______________________________________________________________________

 

Editores del Portal, sitios de especialidades y temáticos.

Editores del Portal, sitios de especialidades y temáticos.

Este es un espacio de intercambio y comunicación sistemática con los editores de los sitios web de especialidades y temas de salud del portal de Infomed. Se abordarán temas de interés específico para su desempeño.

Para enviar un mensaje a todos los miembros de la lista, envíelo a la dirección:  editoresdel portal. Responsable es la Dra. Ivette Cristina Muñiz Rodriguez